Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome

Clinical Endocrinology

Volumn 75, Issue 3, 2011, Pages 378-381

  Rotondi, Mario ^a   Cappelli, Carlo ^b   Magri, Flavia ^a   Botta, Roberta ^a   Dionisio, Rosa ^a   Iacobello, Carmelo ^c   De Cata, Pasquale ^a   Nappi, Rossella E ^a   Castellano, Maurizio ^b   Chiovato, Luca ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c SPEDALI CIVILI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE; METFORMIN; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; EUTHYROIDISM; FEMALE; HASHIMOTO DISEASE; HORMONAL THERAPY; HORMONE DETERMINATION; HUMAN; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; THERAPY EFFECT; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT DURATION;

ADULT; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; HYPOTHYROIDISM; METFORMIN; POLYCYSTIC OVARY SYNDROME; THYROID GLAND; THYROID HORMONES; THYROTROPIN; THYROXINE; TIME FACTORS; TREATMENT OUTCOME; TRIIODOTHYRONINE; YOUNG ADULT;

EID: 79961218545     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04042.x     Document Type: Article

References (18)

1. Scheen, A.J., (2005) Drug interactions of clinical importance with antihyperglycaemic agents: an update. Drug Safety, 28, 601-631. (Pubitemid 41003048)
2. Sahin, M., Tutuncu, N.B., Ertugrul, D., et al. (2007) Effects of metformin or rosiglitazone on serum concentrations of homocysteine, folate, and vitamin B12 in patients with type 2 diabetes mellitus. Journal of Diabetes Complications, 21, 118-123.
3. Wulffele, M.G., Kooy, A., Lehert, P., et al. (2003) Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial. Journal of Internal Medicine, 254, 455-463. (Pubitemid 37346629)
4. Davidson, J.A., &, Chan, J.C.N., (2007) The role of metformin in polycystic ovary syndrome. In:, C.J. Bailey, I.W. Campbell, J.C.N. Chan, et al. eds Metformin: The Gold Standard. John Wiley & Sons, New York, 223-231.
5. Velazquez, E.M., Mendoza, S., Hamer, T., et al. (1994) Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism, 43, 647-654. (Pubitemid 24145474)
6. Dunaif, A., (2008) Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndromea-a reappraisal. Nature Clinical Practice Endocrinology and Metabolism, 4, 272-283. (Pubitemid 351571139)
7. Moll, E., van der Veen, F., &, van Wely, M., (2007) The role of metformin in polycystic ovary syndrome: a systematic review. Human Reproduction Update, 13, 527-537. (Pubitemid 350018522)
8. Creanga, A.A., Bradley, H.M., McCormick, C., et al. (2008) Use of metformin in polycystic ovary syndrome: a meta-analysis. Obstetrics & Gynecology, 111, 959-968. (Pubitemid 351482630)
9. Palomba, S., Falbo, A., Zullo, F., et al. (2009) Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocrine Reviews, 30, 1-50.
10. Palomba, S., Pasquali, R., Orio, F. Jr, et al. (2009) Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis. Clinical Endocrinology 70, 311-321.
11. Vigersky, R.A., Filmore-Nassar, A., &, Glass, A.R., (2006) Thyrotropin suppression by metformin. Journal of Clinical and Endocrinological Metabolism 91, 225-227. (Pubitemid 43069142)
12. Isidro, M.L., Penín, M.A., Nemiña, R., et al. (2007) Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy. Endocrine 32, 79-82. (Pubitemid 350242550)
13. Cappelli, C., Rotondi, M., Pirola, I., et al. (2009) TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients. Diabetes Care, 32, 1589-1590.
14. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility 81, 19-25.
15. Oleandri, S.E., Maccario, M., Rossetto, R., et al. (1999) Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity. Journal of Endocrinological Investigation, 22, 134-140. (Pubitemid 29137407)
16. Janssen, O.E., Mehlmauer, N., Hahn, S., et al. (2004) High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. European Journal of Endocrinology, 150, 363-369. (Pubitemid 38443788)
17. Wakim, A.N., Polizotto, S.L., &, Burholt, D.R., (1995) Influence of thyroxine on human granulosa cell steroidogenesis in vitro. Human Reproduction, 10, 2845-2848.
18. Haugen, B.R., (2009) Drugs that suppress TSH or cause central hypothyroidism. Best Practice & Research Clinical Endocrinology & Metabolism, 23, 793-800.